Cardinal Health Inc. (NYSE:CAH) stock fell on Thursday as the healthcare services company reported mixed earnings performance for the third quarter of 2026.

Earnings Beat But Revenue Falls Short

The company reported adjusted earnings of $3.17 per share, beating the consensus of $2.79.

Sales increased 11% year over year to $60.94 billion, missing the consensus estimate of $61.70 billion. Adjusted operating earnings jumped 18% to $956 million.

Third quarter revenue for the Pharmaceutical and Specialty Solutions segment increased 11% to $56.1 billion, driven by brand and specialty pharmaceutical sales growth from existing customers.

Revenue for the Global Medical Products and Distribution segment was generally flat at $3.1 billion compared to the prior year, reflecting lower distribution volumes, offset by Cardinal Health brand growth.